Local delivery system of cytotoxic agents to tumors by focused sonoporation

Recently, ultrasound-targeting microbubble destruction has been employed in molecular gene therapy, and a new potent nonviral gene transfer method known as ‘sonoporation’ has been developed. We investigated the efficiency of sonoporation toward growth inhibition of human gingival squamous carcinoma cell line, Ca9-22, in vitro and in vivo. The cytotoxicity of bleomycin (BLM) was investigated using flow-cytometric analysis and Hoechst's staining in vitro assay systems. We found that the delivery of BLM by sonoporation induced cytotoxic effect toward Ca9-22 cells in vitro. Our in vivo results showed that tumors nearly disappeared in Ca9-22 cell-implanted nude KSN/slc mice treated with a low dose of BLM followed by sonoporation during the 4-week experimental period. Histological analysis revealed that the cytotoxic effect was mainly apoptosis. We previously reported that the cytolethal distending toxin B (cdtB) from Actinobacillus actinomycetemcomitans, a periodontopathic bacterium, is responsible for cell cycle arrest and apoptosis in vitro. Thus, we used sonoporation to transfect a cdtB-expressing plasmid into Ca9-22 cells and examined cell viability in vitro and in vivo. We found that an administration of cdtB-expressing plasmid followed by sonoporation-induced marked growth inhibition of Ca9-22 cells and apoptotic cells were also observed in vitro and in vivo. These findings suggest that local administration of cytotoxic agents with sonoporation is a useful method for molecular cancer therapy.

[1]  J. Wands,et al.  Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the escherichia coli purine nucleoside phosphorylase gene , 2000, Hepatology.

[2]  L. Mir,et al.  The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway , 2001, British Journal of Cancer.

[3]  S. Horwitz,et al.  Characterization of the association of radiolabeled bleomycin A2 with HeLa cells. , 1984, Cancer research.

[4]  Koichi Ogawa,et al.  Induction of cell-membrane porosity by ultrasound , 1999, The Lancet.

[5]  M. Yoshikawa,et al.  Reconstitution and Purification of Cytolethal Distending Toxin of Actinobacillus actinomycetemcomitans , 2001, Microbiology and immunology.

[6]  X. Mao,et al.  Functional studies of the recombinant subunits of a cytolethal distending holotoxin , 2002, Cellular microbiology.

[7]  M. Jaroszeski,et al.  Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin , 1998, Cancer.

[8]  R. Burger.  Cleavage of Nucleic Acids by Bleomycin. , 1998, Chemical reviews.

[9]  H. Yamagishi,et al.  Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  T. Nishihara,et al.  Microbial etiology of periodontitis. , 2004, Periodontology 2000.

[11]  T. Okinaga,et al.  Delivery of cytolethal distending toxin B induces cell cycle arrest and apoptosis in gingival squamous cell carcinoma in vitro. , 2004, European journal of oral sciences.

[12]  S. Rodriguez-Cuevas,et al.  Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin. , 2001, Archives of medical research.

[13]  K. Yamato,et al.  Role of TGF-β family in osteoclastogenesis induced by RANKL , 2002 .

[14]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.

[15]  L. Hartwell,et al.  Checkpoints: controls that ensure the order of cell cycle events. , 1989, Science.

[16]  K. Tachibana,et al.  In vivo gene transfer into muscle via electro-sonoporation. , 2002, Human gene therapy.

[17]  J. Galán,et al.  A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. , 2000, Science.

[18]  Y. Taniyama,et al.  Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle , 2002, Gene Therapy.

[19]  A. S. Lee,et al.  Glucose-regulated protein (GRP94 and GRP78) genes share common regulatory domains and are coordinately regulated by common trans-acting factors , 1989, Molecular and cellular biology.

[20]  S. Akifusa,et al.  Recombinant Actinobacillus actinomycetemcomitansCytolethal Distending Toxin Proteins Are Required To Interact To Inhibit Human Cell Cycle Progression and To Stimulate Human Leukocyte Cytokine Synthesis , 2001, Infection and Immunity.

[21]  Yang Liu,et al.  Therapeutic ultrasound: Its application in drug delivery , 2002, Medicinal research reviews.

[22]  N. Miyoshi,et al.  Correlation between sonochemistry of surfactant solutions and human leukemia cell killing by ultrasound and porphyrins. , 2003, Free radical biology & medicine.

[23]  K. Shirouzu,et al.  An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice , 2003, Hepatology.

[24]  W. Burgdorf.  A textbook of oral pathology , 1984 .

[25]  L. Mir,et al.  Therapeutic perspectives of in vivo cell electropermeabilization. , 2001, Bioelectrochemistry.

[26]  J. Gehl,et al.  Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs , 1998, Anti-cancer drugs.

[27]  C. Pickett,et al.  The cytolethal distending toxin family. , 1999, Trends in microbiology.

[28]  L. Mir,et al.  Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. , 1993, Cancer research.

[29]  Julie Gehl,et al.  Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. , 2003, Cancer treatment reviews.

[30]  Douglas L. Miller,et al.  Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. , 1997, Ultrasound in medicine & biology.

[31]  K. Tachibana,et al.  Induction of reparative dentin formation by ultrasound-mediated gene delivery of growth/differentiation factor 11. , 2003, Human gene therapy.

[32]  N. Kamata,et al.  Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture. , 1986, Cancer research.

[33]  G. Nicolson.  Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. , 1988, Biochimica et biophysica acta.

[34]  L. Mir,et al.  Bleomycin: revival of an old drug. , 1996, General pharmacology.

[35]  W. G. Shafer,et al.  Textbook of Oral Pathology , 1974 .

[36]  L. Mir,et al.  Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. , 1988, Biochemical pharmacology.

[37]  T. Nishihara,et al.  Involvement of ganglioside GM3 in G(2)/M cell cycle arrest of human monocytic cells induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. , 2005, Infection and immunity.

[38]  Akimasa Nakao,et al.  Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents , 2005, Cancer Gene Therapy.

[39]  Y. Tabata,et al.  Ultrasound enhances the transfection of plasmid DNA by non-viral vectors. , 2003, Current pharmaceutical biotechnology.

[40]  A. Kitamura.  Bleomycin-mediated electrochemotherapy in mouse NR-S1 carcinoma , 2003, Cancer Chemotherapy and Pharmacology.

[41]  K. Tachibana,et al.  Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice--initial results. , 2003, Radiology.

[42]  E. Unger,et al.  Local drug and gene delivery through microbubbles. , 2001, Progress in cardiovascular diseases.